Monoclonal Mouse anti‑Human NRAS / N‑ras Antibody (clone 06, Preservative Free, WB) LS‑C820119
Monoclonal Mouse anti‑Human NRAS / N‑ras Antibody (clone 06, Preservative Free, WB) LS‑C820119
Antibody:
NRAS / N-ras Mouse anti-Human Monoclonal (Preservative Free) (06) Antibody
Format:
Unconjugated, Preservative Free
Overview
Antibody:
NRAS / N-ras Mouse anti-Human Monoclonal (Preservative Free) (06) Antibody
Format:
Unconjugated, Preservative Free
Specifications
Description
N-ras antibody LS-C820119 is an unconjugated mouse monoclonal antibody to human N-ras (NRAS). Validated for ELISA and WB.
Target
Human NRAS / N-ras
Synonyms
NRAS | HRAS1 | NRAS1 | NS6 | ALPS4 | Transforming protein N-Ras | N-ras | N-ras protein part 4 | GTPase NRas
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Protein A purified
Modifications
Preservative Free
Immunogen
Recombinant Human NRAS / N-Ras protein
Applications
- Western blot (1:500 - 1:2000)
- ELISA (1:1000 - 1:2000)
Usage
Applications should be user optimized.
Presentation
0.2 µm filtered solution in PBS
Storage
Store at 2°C to 8°C for up to 1 month. Aliquot and store at -20°C to -80°C for up to 1 year. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Bat, Bovine, Dog, Horse, Pig
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Flow Cytometry
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, IHC - Frozen
Species:
Human, Rat
Applications:
Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/31/2024